Phase II and Phase III Catalyst Monitor: Q3 2025 Outlook Report - Upcoming FDA Decisions Drive Momentum in Biopharma with Key Catalysts Across GHD, PKU, Presbyopia, and Wet AMD TreatmentsGlobeNewsWire • 07/22/25
Nearly 89% of Companies are Seeing Insider Selling, But these 3 are Seeing Substantial Buying24/7 Wall Street • 07/22/25
Nvidia and AMD Shares Jump With Sales Set to Resume to China. Is It Too Late to Buy the Stocks?The Motley Fool • 07/22/25
Embedded LLM Launches First-of-its-Kind Monetisation Platform for AMD AI GPUsGlobeNewsWire • 07/22/25
Advanced Micro Devices (NASDAQ: AMD) Price Prediction and Forecast 2025-2030 (July 2025)24/7 Wall Street • 07/19/25
This Artificial Intelligence (AI) Stock Looks Set for a Second-Half ComebackThe Motley Fool • 07/19/25
Stock Market Hits Highs On Nvidia AI Chip News, Taiwan Semi Earnings, Economic Data: Weekly ReviewInvestors Business Daily • 07/18/25
1 Artificial Intelligence (AI) Stock to Buy Before It Jumps 37%, According to a Wall Street AnalystThe Motley Fool • 07/18/25
Eye Spear Analysis Report 2025 | Market to Reach $265.6 Million by 2032, Driven by Rising Prevalence of Eye Disorders Like Cataracts, Glaucoma, and AMDGlobeNewsWire • 07/18/25